Previous close | 279.31 |
Open | 280.75 |
Bid | 280.44 x 1200 |
Ask | 281.06 x 3000 |
Day's range | 279.57 - 283.50 |
52-week range | 261.59 - 431.79 |
Volume | |
Avg. volume | 211,546 |
Market cap | 7.981B |
Beta (5Y monthly) | 0.88 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
National Vision (EYE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ATNI, ABR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2023.